<DOC>
	<DOCNO>NCT00269399</DOCNO>
	<brief_summary>The purpose study assess treatment safety 10-day course rifaximin ( Xifaxan ) compare vancomycin treatment Clostridium difficile-associated diarrhea ( CDAD ) .</brief_summary>
	<brief_title>A Trial Compare Xifaxan Vancomycin Treatment Clostridium Difficile-Associated Diarrhea ( CDAD )</brief_title>
	<detailed_description>Clostridium difficile bacterium proliferate normal colonic flora alter , commonly due antibiotic use . Clostridium difficile non-invasive localize lumen colon . Once establish , produce 2 potent toxin , A B . The principal reservoir Clostridium difficile hospital environment , risk acquire Clostridium difficile increase direct proportion length hospital stay . Patients CDAD typically present profuse watery mucoid diarrhea cramp abdominal pain . Additional symptom include fever , nausea , anorexia , malaise , bloody stool . More severe case may complicate dehydration , electrolyte disturbance , ileus , peritonitis . Systemic manifestation may include prerenal azotemia , sepsis syndrome , toxic colitis . White blood cell count ( WBCs ) also may markedly elevate shift immature form . Extreme presentation fulminant colitis may require colectomy even result death . Symptoms CDAD may begin day initiation antibiotic therapy 8 week discontinuation .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Clostridium Infections</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Subject 18 year age old , acute diarrhea least 1 sign enteric infection present , fever , nausea/loss appetite , vomit , severe abdominal pain discomfort . Subject positive Clostridium difficile stool toxin assay screen Subject previous episode clinically diagnose Clostridium difficile within past 6 month . Subject chronic disease associate diarrhea ( e.g. , inflammatory bowel disease diarrhea predominant irritable bowel syndrome [ DIBS ] ) Subject therapy agent administer treatment Clostridium difficile prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Clostridium difficile-associated Diarrhea ( CDAD )</keyword>
	<keyword>CDAD</keyword>
	<keyword>C diff</keyword>
</DOC>